European Journal of Internal Medicine
Volume 20, Issue 4 , Pages 373-377 , July 2009

Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: A comparative study with Italian mainland

  • Sandro Muntoni

      Affiliations

    • Department of Toxicology, Unit of Oncology and Molecular Pathology, University School of Cagliari, Cagliari, Italy
    • Centre for Metabolic Diseases and Atherosclerosis, The ME.DI.CO. Association, Cagliari, Italy
    • Corresponding Author InformationCorresponding author. Department of Toxicology, Unit of Oncology and Molecular Pathology, University School of Cagliari, Via Porcell 4 09124 Cagliari, Italy. Tel.: + 39 070 6758634; fax: + 39 070 666062.
    • ,
  • Luigi Atzori

      Affiliations

    • Department of Toxicology, Unit of Oncology and Molecular Pathology, University School of Cagliari, Cagliari, Italy
    • ,
  • Roberto Mereu

      Affiliations

    • Department of Toxicology, Unit of Oncology and Molecular Pathology, University School of Cagliari, Cagliari, Italy
    • ,
  • Antonio Manca

      Affiliations

    • Third Medical Division, Unit of Diabetes and Metabolic Diseases, SS. Annunziata Hospital, Sassari, Italy
    • ,
  • Graziella Satta

      Affiliations

    • Department of Medical, Internistic and Anestesiological Sciences, Chemical–Clinical Laboratories Unit, University School of Cagliari, Italy
    • ,
  • Alessandro Gentilini

      Affiliations

    • Third Medical Division, Unit of Diabetes and Metabolic Diseases, SS. Annunziata Hospital, Sassari, Italy
    • ,
  • Paolo Bianco

      Affiliations

    • Third Medical Division, Unit of Diabetes and Metabolic Diseases, SS. Annunziata Hospital, Sassari, Italy
    • ,
  • Antonio Baule

      Affiliations

    • Third Medical Division, Unit of Diabetes and Metabolic Diseases, SS. Annunziata Hospital, Sassari, Italy
    • ,
  • Giovanni Maria Baule

      Affiliations

    • Third Medical Division, Unit of Diabetes and Metabolic Diseases, SS. Annunziata Hospital, Sassari, Italy
    • ,
  • Sergio Muntoni

      Affiliations

    • Centre for Metabolic Diseases and Atherosclerosis, The ME.DI.CO. Association, Cagliari, Italy

Received 17 March 2008 ,Revised 8 October 2008 ,Accepted 24 October 2008.

References 

  1. Labarthe DR. In: Epidemiology and prevention of cardiovascular diseases: a global challenge. J Public Health Policy. Gaithersberg, MD: Aspen Publishers; 1998;
  2. Bairey Merz CN, Dwyer J, Nordstrom CK, Walton KG, Salerno JW, Schneider RH. Psychosocial stress and cardiovascular disease: pathophysiological links. Behav Med. 2002;27:141–147[Winter]
  3. Bau PF, Bau CH, Rosito GA, Manfroi WC, Fuchs FD. Alcohol consumption, cardiovascular health, and endothelial function markers. Alcohol. 2007;41:479–488
  4. Greenlund PD, Coolidge JN, Fan AZ. Trends in cholesterol screening and awareness of high blood cholesterol — United States 1991–2003. JAMA. 2005;294:2021–2022
  5. Lyratzopoulos G, McElduff P, Heller RP, Hanily M, Lewis PS. Comparative levels and time trends in blood pressure, total cholesterol, body mass index and smoking among Caucasians and South-Asian participants of a UK primary-care based cardiovascular risk factor screening program. BMC Public Health. 2005;5:125
  6. Kastarinen MJ, Salomaa VV, Vartiainen EA, et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens. 1998;16:1379–1387
  7. Molarius A, Parsons RW, Dobson AJ, et al. for WHO MONICA Project Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health. 2001;91:206–212
  8. The Research Group ATS-RF2 of the Italian National Research Council . Distribution of some risk factors for atherosclerosis in nine Italian population samples. Am J Epidemiol. 1981;113:338–346
  9. The Research Group ATS-RF2-OB43 of the Italian National Research Council . Time trends of some cardiovascular risk factors in Italy. Am J Epidemiol. 1987;126:95–103
  10. Muntoni S, Pintus F, Mascia P, et al. Mean levels and distribution of some risk factors for atherosclerosis in Sardinia: the ATS-Sardegna survey. Eur J Epidemiol. 1991;7:39–47
  11. Menotti A, Scanga M the Responsible Investigators of the RF2 OB43 and MICOL Research Groups. Trends in coronary risk factors in Italy. Int J Epidemiol. 1992;21:883–891
  12. Menotti A, Seccareccia F, Lanti M The RIFLE Project Research Group. Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970s and the 1980s. In: The talian RIFLE Pooling Project. Risk Factors and Life Expectancy. Giorn Ital Cardiol. vol. 5:1995;p. 1539–1572
  13. Muntoni Sa, Stabilini L, Stabilini M, Muntoni S. Results of five-year community-based programme for cardiovascular disease prevention: the ATS-Sardegna Campaign. Eur J Epidemiol. 1999;15:29–34
  14. Vanuzzo D, Pilotto L, Uguccioni M, et al. Epidemiologia cardiovascolare: andamento dei fattori di rischio in Italia. Ital Heart J. 2004;5(suppl 8):19S–27S
  15. Regione Autonoma della Sardegna: Prevenzione e diagnosi precoce delle malattie cardiovascolari. Deliberazione della Giunta Regionale no 44/3 del 17/11/1997.
  16. Menotti A. Cardiovascular risk factors in Italy. Prev Med. 1999;29:S111–S118
  17. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. In: The JNC 7 Report. JAMA. vol. 19:2003;p. 2560–2572
  18. Gavin JR, Alberti KGMM, Davidson MB, et al. for the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (American Diabetes Association) In: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. vol. 20:1997;p. 1183–1197
  19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report on the NationalCholesterol Education Program (NCEP). JAMA. 2001;285:2486–2497
  20. Marcovina SM, Albers JJ, Henderson LO, Hannon WH. International Federation of Clinical Chemistry: standardization project for measurements of apolipoprotein A-1 and B. III. Comparability of apolipoprotein A-1 values by use of international reference material. Clin Chem. 1993;39:777–781
  21. Koschinsky ML, Marcovina SM. Lipoprotein(a): structural implications for pathophysiology. Int J Clin Lab Res. 1997;27:14–23
  22. American Society of Human Genetics/American College of Medical Genetics Test and Technology Transfer Committee Working Group . ASHG/ACMG Statement. Measurement and use of total plasma homocysteine. Am J Human Genet. 1998;63:1541–1543
  23. Haltmayer M, Mueller T, Gegenhuber A, Poelz W. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination. Clin Lab. 2004;50:175–180
  24. Gruppo di Ricerca ATS-Sardegna . I fattori di rischio dell'arteriosclerosi in Sardegna. Giorn Arterioscler. 1987;12:115–191
  25. World Health Organization . Health for all statistical database. 2004;www.who.dk
  26. Statistiche in breve. Istituto Nazionale di Statistica. L'uso e l'abuso di alcool in Italia. Anno 2006. www.istat.it.
  27. Schwandt P. The triglyceride controversy: a review of the data. Eur Heart J. 1990;11(suppl H):38–43
  28. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest. 1990;85:1709–1715
  29. Helmhold M, Bigge J, Muche R, et al. Contribution of the apo[a] phenotype to plasma Lp[a] concentrations shows considerable ethnic variation. J Lipid Res. 1991;32:1919–1928
  30. Cavalli-Sforza LL, Piazza A. Human genomic diversity in Europe: a summary of recent research and prospects for the future. Eur J Hum Genet. 1993;1:3–18
  31. Aydenian H, Fadel MA, Baddoura R. Epidemiological study of hyperlipemia in a Lebanese population. Ann Biol Clin. 1999;57:697–703
  32. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28:850–856
  33. Margaglione M, DiMinno G, Grandone E, et al. Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Arterioscler Thromb Vasc Biol. 1996;16:120–128
  34. Cocco P, Todde P, Fornara S, Manca MB, Manca P, Sias AR. Mortality in a cohort of men expressing the glucose 6-phosphate dehydrogenase deficiency. Blood. 1998;91:706–709
  35. Muntoni S, Stabilini L, Muntoni Sa. Esperienza maturata in campagne nutrizionali: Regione Sardegna. In:  Ricci G,  Urbinati G editor. 2a Consensus Conference Italiana “Abbassare la colesterolemia per ridurre la cardiopatia coronarica”. Relazione degli Esperti. Roma: CIC Edizioni Internazionali; 1997;p. 327–333
  36. de Lorgeril M, Salen P. Modified Cretan Mediterranean diet in the prevention of coronary heart disease and cancer: an update. In:  Simopoulos AP,  Visioli V editor. More on Mediterranean Diet. World Rev Nutr Diet. vol. 97:Basel: Karger; 2007;p. 1–32
  37. Meloni L, Manca MR, Loddo I, Cioglia G, Cocco P, Schwartz A, et al. Glucose-6-phosphate dehydrogenase deficiency protects against coronary heart disease. J Inherit Metab Dis. 2008;31:412–417
  38. Muntoni S. Prevention of cardiovascular disease: from biomedical research to health policy. Eur J Epidemiol. 1995;11:485–494

PII: S0953-6205(08)00301-4

doi: 10.1016/j.ejim.2008.10.007

European Journal of Internal Medicine
Volume 20, Issue 4 , Pages 373-377 , July 2009

Article Tools